• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Quantifying the reduction of primary breast cancer associated with exercise

bySimon PanandAlex Chan
June 16, 2024
in Chronic Disease, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Across a follow-up period of approximately 5 years, there was a non-linear relationship between exercise at breast cancer diagnosis and distant recurrence-free interval (DRFI), with greater exercise exposure up to a certain threshold correlating with greater reductions in the risk of recurrence.

2. The relationship between the level of exercise at diagnosis and DRFI events was only observed in the premenopausal population and not the postmenopausal population.

Evidence Rating Level: 2 (Good)

While studies have shown that exercise both before and after breast cancer (BC) diagnosis is associated with reduced mortality, the association between exercise and disease recurrence after BC diagnosis has not been thoroughly investigated. This multicentre prospective cohort therefore sought to evaluate the relationship between exercise dose and distant recurrence-free interval (DRFI) in BC. Between March 2012 and February 2018, 10,359 patients (mean [SD] age = 56.3 [11.2] years) with stage I-III BC were assessed at baseline and follow-up visits at 1, 2, 4 and 6 years following diagnosis. To account for potential confounding variables that could influence exercise dose at diagnosis, propensity score inverse probability (IPTW) Cox models were used (n = 9,051). Exercise dose was obtained by multiplying the weekly activity session frequency by the average session duration, weighted by the corresponding standardized metabolic equivalent of task (MET) value to yield a total MET-hours per week (MET-h/wk). Across the overall cohort, there was a nonlinear relationship between pre-treatment exercise and DRFI (P = 0.0097), with exercise dose beyond 5 MET-h/wk showing an inverse linear reduction in recurrence risk up to a threshold of 25 MET-h/wk. When comparing an exercise dose of <5 MET-h/wk to an exercise dose of ≥ 5 MET-h/wk in the IPTW population, the adjusted hazard ratio was 0.82 (95% CI = 0.67 to 1.00). Interestingly, this relationship between pre-treatment exercise and DRFI was only observed in the IPTW premenopausal cohort and not the IPTW postmenopausal cohort. Overall, this study found that the relationship between exercise dose at BC diagnosis and risk of DRFI events is nonlinear and further studies investigating the antitumour activity of exercise therapy are warranted. 

Click to read the study in JCO

Image: PD

RELATED REPORTS

Replacing sedentary time with physical activity may lower risk of all-cause mortality

Breast cancer screening with MRI provides modest benefit for high-risk women

Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: Breast Cancercancerexerciselifestyle modificationsoncology
Previous Post

Telephone coaching program may help patients achieve weight loss

Next Post

2 Minute Medicine Rewind June 17, 2024

RelatedReports

Reduced gestational weight gain with lifestyle intervention
Cardiology

Replacing sedentary time with physical activity may lower risk of all-cause mortality

March 2, 2026
Quick Take: Diffusion-weighted Imaging of Invasive Breast Cancer: Relationship to Distant Metastasis–free Survival
Oncology

Breast cancer screening with MRI provides modest benefit for high-risk women

March 2, 2026
2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]
AI Roundup

Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy

February 20, 2026
Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma
Weekly Rewinds

2 Minute Medicine Rewind February 16, 2026

February 16, 2026
Next Post
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

2 Minute Medicine Rewind June 17, 2024

Patient Basics: Large Cell Cancer of the Lung

Osimertinib significantly improved progression-free survival in patients with unresectable stage III non-small cell lung cancer

Differential RNA expression in late onset fetal growth restriction

Neoadjuvant Immunotherapy in Mismatch Repair–Deficient Colon Cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Shingles vaccine and sildenafil linked to lower Alzheimer’s risk
  • Glucagon-like peptide-1 receptor agonists are associated with reduced risk of developing substance use disorders
  • Oral infigratinib boosts growth velocity in achondroplasia study
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.